Occult Nodal Metastases in Patients Down-Staged to Nonmuscle Invasive Disease Following Neoadjuvant Chemotherapy
- 5 April 2020
- journal article
- research article
- Published by Elsevier BV in Urology
- Vol. 142, 155-160
- https://doi.org/10.1016/j.urology.2020.03.021
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial CarcinomaCancer Discovery, 2014
- Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerEuropean Urology, 2014
- Pathological T0 Following Radical Cystectomy with or without Neoadjuvant Chemotherapy: A Useful SurrogateJournal of Urology, 2014
- Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapyBJU International, 2011
- Stage pT0 at Radical Cystectomy Confers Improved Survival: An International Study of 4,430 PatientsJournal of Urology, 2010
- A Sequential Treatment Approach to Myoinvasive Urothelial Cancer: A Phase II Southwest Oncology Group Trial (S0219)Journal of Urology, 2009
- Outcome of Patients Who Refuse Cystectomy after Receiving Neoadjuvant Chemotherapy for Muscle-Invasive Bladder CancerEuropean Urology, 2008
- Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data: Advanced Bladder Cancer (ABC) Meta-analysis CollaborationEuropean Urology, 2005
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerThe New England Journal of Medicine, 2003
- Can patient selection for bladder preservation be based on response to chemotherapy?Cancer, 2003